Clinical Trial: Study on Efficacy and Safety of 1565 nm Non-ablative Fractional Laser Combined with Salicylic Acid in the Treatment of Melasma: A Single-center, Randomized Split-face Trial (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on Efficacy and Safety of 1565 nm Non-ablative Fractional Laser Combined with Salicylic Acid in the Treatment of Melasma: A Single-center, Randomized Split-face Trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129436

Registration Time: 2026/08/04

Type: Interventional study

Primary Sponsor: Shenzhen Center for Chronic Disease Control

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336275

Published by HT Digital Content Services with permission from Health Daily Digest....